Although high expression of most DEMs indicated a longer survival time of patients with colon cancer (Fig. S1C), only that of SLC25A5 (HR = 0.58, log-rank p < 0.01, 95% CI 0.38–0.90) and SLC25A24 (HR = 0.58, log-rank p < 0.01, 95% CI 0.39–0.85) met statistical significance (Fig. 2E). This evidence concerns the gene SLC25A5 and malignant colon neoplasm.